
Viking Therapeutics: A Silent Revolution in Biotech?
Viking Therapeutics is innovating in metabolic and endocrine disorders with a focus on SARMs. Drug candidates like VK2809 and VK0214 are showing promise in treating lipid and liver disorders. The company leverages less conventional paths such as SARMs over gene editing approaches.